Impact of MenAfriVac on Meningococcal A Meningitis in Cameroon: A Retrospective Study Using Case-by-Case-Based Surveillance Data from 2009 to 2015

Meningococcal meningitis is a public health concern in Africa. Conjugated vaccine against serogroup A Neisseria meningitidis (MenAfriVac) was used in mass vaccination and was proved to have a good impact in the meningitis belt. There is a lack of information about the impact of this intervention in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gake, Bouba, Babinne Graobe, Bonaventure, Abdouraman, Bouba, Satou Ngah, Crescence, Aissatou, Ahmadou, Gake, Nelly-Michèle, Seukap, Elise Claudine, Nchiwan Nukenine, Elias, Etoundi Mballa, Alain G., Fonkoua, Marie-Christine, Lombart, Jean-Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490062/
https://www.ncbi.nlm.nih.gov/pubmed/34616456
http://dx.doi.org/10.1155/2021/4314892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490062/
https://www.ncbi.nlm.nih.gov/pubmed/34616456
http://dx.doi.org/10.1155/2021/4314892

Ejemplares similares